FREE TREATMENT REPORT
See ratings and reviews when you sign up for an account.
Evaluation of Intercarpal Botox Versus Steroid Injections for Carpal Tunnel Syndrome
This study is currently Recruiting
November 2010 By University of Minnesota - Clinical and Translational Science Institute
First Recieved on June 17, 2008
Last Updated on November 1, 2010
To compare local steroid injections to local Botulinum toxin A injection in a double-blinded
||Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment
Resources/Links provided by NLM:
|Study Start Date:
|Estimated Primary Completion Date:
Corticosteroid injection into Carpal Tunnel
Botulinum toxin injection into Carpal Tunnel
45 units Botox injected into Carpal Tunnel once
|Drug:Corticosteroid injection into Carpal Tunnel|
40 mg Triamcinolone with one mL 1% lidocaine injected once into Carpal Tunnel
|Ages Eligible for Study:||18 Years|
|Genders Eligible for Study:||Both|
|Accepts Healthy Volunteers:||No|
- Any individual with symptoms of carpal tunnel syndrome and a diagnosis of CTS either
clinically or via EMG will be included into this study. There will be a total of 20
subjects displaying symptoms of CTS. The gender of the subjects will not determine
enrollment. There is no requirement of male to female ratio for this study. There
is no age cut-off or minimal age requirement to enroll in the study. No specific
Racial or ethnic restrictions will be present for this study. Female subjects of
childbearing potential (not surgically sterile or postmenopausal for at least 2
years) must have a negative pregnancy test at screening.
1. Any individual who has a diagnosis of CTS (by EMG or other means) but no symptoms of
CTS will be excluded from this study.
2. Vulnerable subjects as defined as children, pregnant women, those with limited
autonomy, decisional incapacity and prisoners will not be enrolled in this study.
3. Individuals with any history of carpal tunnel release surgery and recurrent or
persistent symptoms will be excluded form this study.
4. Subject is pregnant or lactating.
- Investigator: Dennis Dykstra, MD - Principal Investigator - University of Minnesota - Clinical and Translational Science Institute